Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bayesian Clinical Trials.
Clark J, Muhlemann N, Ionan A. Clark J, et al. Among authors: ionan a. Ther Innov Regul Sci. 2023 May;57(3):399-400. doi: 10.1007/s43441-023-00498-1. Epub 2023 Jan 31. Ther Innov Regul Sci. 2023. PMID: 36719596
Correction to: Bayesian Clinical Trials.
Clark J, Muhlemann N, Ionan A. Clark J, et al. Among authors: ionan a. Ther Innov Regul Sci. 2023 May;57(3):401. doi: 10.1007/s43441-023-00519-z. Ther Innov Regul Sci. 2023. PMID: 37022645 No abstract available.
FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy.
Przepiorka D, Le RQ, Ionan A, Li RJ, Wang YH, Gudi R, Mitra S, Vallejo J, Okusanya OO, Ma L, Yang Y, Patel P, Mezaache D, Shah R, Banerjee A, McLamore S, Maung AN, Goldberg KB, Pazdur R, Theoret MR, De Claro RA. Przepiorka D, et al. Among authors: ionan a. Clin Cancer Res. 2022 Jun 13;28(12):2488-2492. doi: 10.1158/1078-0432.CCR-21-4176. Clin Cancer Res. 2022. PMID: 35135839 Free PMC article.
A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4.
Alsina L, Israelsson E, Altman MC, Dang KK, Ghandil P, Israel L, von Bernuth H, Baldwin N, Qin H, Jin Z, Banchereau R, Anguiano E, Ionan A, Abel L, Puel A, Picard C, Pascual V, Casanova JL, Chaussabel D. Alsina L, et al. Among authors: ionan a. Nat Immunol. 2014 Dec;15(12):1134-42. doi: 10.1038/ni.3028. Epub 2014 Oct 26. Nat Immunol. 2014. PMID: 25344726 Free PMC article.
Analysis of the expression of human tumor antigens in ovarian cancer tissues.
Ali-Fehmi R, Chatterjee M, Ionan A, Levin NK, Arabi H, Bandyopadhyay S, Shah JP, Bryant CS, Hewitt SM, O'Rand MG, Alekseev OM, Morris R, Munkarah A, Abrams J, Tainsky MA. Ali-Fehmi R, et al. Among authors: ionan a. Cancer Biomark. 2010;6(1):33-48. doi: 10.3233/CBM-2009-0117. Cancer Biomark. 2010. PMID: 20164540 Free PMC article.
Autoantibody approach for serum-based detection of head and neck cancer.
Lin HS, Talwar HS, Tarca AL, Ionan A, Chatterjee M, Ye B, Wojciechowski J, Mohapatra S, Basson MD, Yoo GH, Peshek B, Lonardo F, Pan CJ, Folbe AJ, Draghici S, Abrams J, Tainsky MA. Lin HS, et al. Among authors: ionan a. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2396-405. doi: 10.1158/1055-9965.EPI-07-0318. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006929 Free PMC article.
Pathways to implementation of serum proteomics for cancer.
Chatterjee M, Levin NK, Shah JP, Ionan A, Grates HE, Tainsky MA. Chatterjee M, et al. Among authors: ionan a. Expert Opin Med Diagn. 2007 Sep;1(1):3-15. doi: 10.1517/17530059.1.1.3. Expert Opin Med Diagn. 2007. PMID: 23489265
12 results